A

Axogen

D
AXGN
USD
-2.05
(-13.3812%)
Market Closed
41,041.00
Volume
0.05
EPS
-
Div Yield
-34.025641
P/E
581,621,459.27
Market Cap
Today
-13.3812%
1 Week
-5.147%
1 Month
-3.209%
6 Months
127.616%
12 Months
145.741%
Year To Date
94.006%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ISRG
ISRG
4.01
(0.7705%)
USD
MDT
MDT
-1.99
(-2.2084%)
USD
Z
ZBH
-1.51
(-1.3702%)
USD
SYK
SYK
0.72
(0.195%)
USD
EW
EW
0.09
(0.1369%)
USD
A
ALGN
-2.53
(-1.1249%)
USD
A
ABMD
(%)
USD
TMO
TMO
-3.64
(-0.6504%)
USD
BSX
BSX
0.45
(0.5205%)
USD
M
MMSI
-0.51
(-0.4974%)
USD
JNJ
JNJ
-1.03
(-0.6528%)
USD
MDT
MDT
-1.99
(-2.2084%)
USD
N
NUVA
-0.72
(-1.769%)
USD

Title:
Axogen

Sector:
Healthcare
Industry:
Medical Devices
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Do you need help or have a question?
Contact Us